Clinical Trial Update: Combined Therapy With Peginterferon Alfa-2a With NA in NA-treated HBeAg Positive Patients [Phase 4]

View source ↗

Summary

This entry describes a Phase 4 clinical trial update of a combination therapy with peginterferon alfa-2a and a nucleoside analogue in HBeAg-positive chronic hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Nucleos(t)ide analogue (NA) (nucleos(t)ide analogue)
• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Ruijin Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN